When “Safe” Products Become a Safety Lesson The U.S. Food and Drug Administration (FDA) recently announced a recall of several cholesterol-lowering medications after routine testing detected nitrosamine impurities — chemicals that can increase cancer risk following long-term exposure. For patients, the immediate health risk is low.
For scientists, regulators, and developers, however, this is a powerful reminder: